London: Interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India and known as Covaxin, reports that two doses offer 77.8% protection against symptomatic COVID-19 ...
New York: By the time the Taliban took over Afghanistan in mid-August, at the main hospital in Maidan Shar, a city of 35,000 in the center of the country, many of the staff had been paid ...
New York: Efforts to boost COVID-19 vaccine production should be matched by access to the syringes needed to inject them - and there could even be a global shortage of needles for regular ...
Dhaka: Bangladesh recorded three new deaths due to COVID-19 in the past 24 hours, media reports said.
Pharmaceutical giant Pfizer Inc on Friday announced its investigational novel COVID-19 oral antiviral candidate,PAXLOVID, significantly reduced hospitalization and death, based on an inte ...
Wellington/UNI/Xinhua: The addition of another drug to the suite of COVID-19 medicines available in New Zealand is good news for patients and for the health system, Health Minister Andrew ...
Canberra/UNI/Xinhua: Australia's peak medical body has warned the nation's hospital system is under severe pressure despite a significant drop in patient numbers during the Covid- ...
New York: About 22 months since the first cases of COVID-19 were reported, and almost a year since the first vaccines were approved, reported cases and deaths from the virus are increasin ...
Delhi (JEN): Indian Prime Minister Narendra Modi on Wednesday said coronavirus vaccines should now be taken to the doorsteps of the people, and there should be an equal focus on the secon ...
- Bangladesh registers 7 new deaths due to COVID-19
- Bangladesh registers zero COVID-19 deaths in past 24 hours
- Vietnam capital urges anti-Covid measures as transmissions hit record points
- Evidence points to animal market, not lab, as epicenter of COVID-19 pandemic: Study
- Austria to impose full lockdown amid rising COVID-19 cases
